Posted Tue, Aug, 07,2012
We offer a selection of ways to follow our journals. We invite readers to choose the channels that best suit their needs, while authors can be certain that their papers will be widely announced when published.
Our email services are the fastest way to get the latest updates. Our journal and subject opt-in email alerts announce new and forthcoming articles within hours of publication and also journal news. Weekly and monthly articles published email alerts are also available.
Every journal and subject has a Twitter account containing new and forthcoming article announcements within hours of publication.
Our recently launched Facebook page contains a weekly list of articles published and separate announcements of notable papers.
Every journal and subject has an RSS feed, perfect for use in your RSS reader or Outlook.
To find more options to follow our journals just scroll to the bottom of this page for a full list.
Thu 23 May, 2013Behavioral Lifestyle Interventions
Thu 23 May, 2013Published This Week (20 to 24 May)
Wed 22 May, 2013Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC/D)
Working with the editorial staff and reviewers for Clinical Medicine Insights: Therapeutics was a positive experience. The online submission/revision process was easy and staff were readily available to answer any questions. Reviewers were knowledgeable, lending expert comments that allowed for improvement in content information. I highly recommend others practitioners and researchers to consider Libertas Academica journals for their next publication.
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)